Alveolar Echinococcosis- Information, Treatment & Prevention
Alveolar echinococcosis (AE) is a chronic disease with a presymptomatic phase that may live for years before signs and symptoms produce. The variance of the signs and symptoms depends on the position of the lesions, which may produce in the liver and in respective organs or tissues, particularly the lungs, mind, and bones. Alveolar echinococcosisis caused by tumor-like or cyst-like tapeworm larvae growing in the system. AE normally involves the liver, but can scatter to new organs of the system. Because the cysts are slow-growing, transmission with AE may not develop any symptoms for many years. Similar to several new parasitic diseases, alveolar echinococcosis appears as a frigid disease. The power of the organism to taint a host and the hardship of disease formerly successfully inoculated bet on the receptivity of the host.
Risk factors for alveolar echinococcosis include an agricultural occupation and a prolonged stay in an endemic area. Pain or discomfort in the upper abdominal region, weakness, and weight loss may occur as a result of the growing cysts. Symptoms may mimic those of liver cancer and cirrhosis of the liver. Alveolar echinococcosis is a zoonosis. In most regions, environmental features that favor the parasite cycle include hilly landscapes, cool and rainy climates, and pastures for cattle breeding. In nature, humans and other animals share the infection, which results in various factors that allow the parasite to complete its life cycle. Contact with the infectious form of the cestode depends on human behavior and cultural habits. Prevalence among wild foxes and coyotes is high, and may reach over 50% in some areas; however, even in these areas, transmission to humans has been low.
Surgery is the popular form of treatment for alveolar echinococcosis, after all removal of the entire parasite mass is not always accessible. Intravenous amphotericin B may be used as rescue chemotherapy in patients resistant or intolerant to benzimidazoles. Interferon gamma (currently in a pilot trial) and nitazoxanide are under evaluation. After surgery, medication may be necessary to keep the cyst from growing back. Use propranolol to prevent digestive bleeding related to portal hypertension. When radical surgery is impossible, one option is nonradical liver resection to reduce the parasitic mass and to increase the chances of effective chemotherapy. These palliative resections, as well as other types of palliative surgery performed to treat complications of disease, may generate specific complications. Consider liver transplantation may be used in very advanced cases.
